KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Change in Acquisitions & Divestments: 2009-2024

Historic Change in Acquisitions & Divestments for Biocryst Pharmaceuticals (BCRX) over the last 16 years, with Dec 2024 value amounting to $320.5 million.

  • Biocryst Pharmaceuticals' Change in Acquisitions & Divestments rose 30.72% to $6.5 million in Q4 2015 from the same period last year, while for Dec 2015 it was $42.4 million, marking a year-over-year increase of 24.74%. This contributed to the annual value of $320.5 million for FY2024, which is 16.78% down from last year.
  • According to the latest figures from FY2024, Biocryst Pharmaceuticals' Change in Acquisitions & Divestments is $320.5 million, which was down 16.78% from $385.1 million recorded in FY2023.
  • Biocryst Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $385.1 million during FY2023, with a 5-year trough of $28.2 million in FY2021.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $320.5 million (2024), whereas its average is $274.3 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first tumbled by 46.52% in 2020, then surged by 316.28% in 2022.
  • Over the past 5 years, Biocryst Pharmaceuticals' Change in Acquisitions & Divestments (Yearly) stood at $43.5 million in 2020, then crashed by 35.13% to $28.2 million in 2021, then soared by 316.28% to $117.4 million in 2022, then spiked by 228.02% to $385.1 million in 2023, then declined by 16.78% to $320.5 million in 2024.